Newsroom

RhythMedix’ RhythmStar System for arrhythmia monitors over 23,000 patients

The RhythmStar Remote Cardiac Monitoring System functions in three monitoring modes, Holter, which records a patient’s heart rhythm for one to two days; Event, worn for 30 days by patients who have infrequent cases of arrhythmia; and Mobile Cardiac Telemetry (MCT), which provides real-time monitoring and analysis by a registered nurse.
Read More

RhythMedix® exceeds first year projections; monitors over 23,000 patients on innovative RhythmStar® Remote Cardiac Monitoring System

RhythMedix today announced that over 23,000 patients at sites across the U.S. have used the RhythmStar System after market entry in March 2015. To support commercialization, the company has undergone a rigorous non-infringement patent assessment process and secured a multi-million-dollar litigation patent defense insurance policy from Intellectual ...
Read More

RhythMedix receives notice of pending ISO13485 registration from Perry Johnson Registrars, Inc.

Read More

RhythMedix Announces its Monitoring Center approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF)

RhythMedix Announces AT&T Mobility network approval and certification for its RhythmStar System

Small Business Week: Rhythmedix (Mount Laurel) feels its wireless device is a breakthrough in cardiac monitoring

Read More

RhythMedix® Announces FDA Clearance, U.S. Launch of RHYTHMSTAR® Mobile Cardiac Monitoring System

RhythMedix announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its RHYTHMSTAR® Mobile Cardiac Monitoring System. The RHYTHMSTAR system is the first cloud-based, all-in-one patient monitoring solution to assist physicians in timely and accurate diagnoses of cardiac abnormalities.
Read More